The American Medical Association urges greater transparency and oversight for imaging AI to maximize trust and patient safety.
Key Details
- 1AMA passed a resolution advocating for explainable AI tools in radiology and other fields.
- 2The association calls for third-party oversight of AI algorithms rather than relying solely on vendor claims.
- 3AMA emphasizes the need for detailed explanations of AI outputs, especially given potential 'life or death consequences.'
- 4Intellectual property concerns should not outweigh the need for explainable AI in medicine.
- 5Lack of explainability may put physicians in difficult positions and undermine their clinical judgment.
Why It Matters
The AMA's stance highlights the critical need for trustworthy AI tools in radiology, impacting both provider decision-making and patient care. Increased transparency and oversight may shape future AI regulations, adoption, and industry practices.
Source
Radiology Business
Related News
•Radiology Business
Radiology Partners Urges FDA for Clarity on Imaging AI Regulations
Radiology Partners and Mosaic Clinical Technologies petition the FDA for clearer regulatory guidelines on imaging AI vision-language models.
•Radiology Business
FDA Solicits Public Input on Regulating Generative AI in Medical Devices
The FDA is seeking public feedback on how to regulate generative AI in medical devices, recognizing both its promise and risks.
•HealthExec
AI's Role in Eliminating Cervical Cancer: A Model for Disease Prevention
Researchers highlight how AI can accelerate the elimination of cervical cancer and set a precedent for combating other diseases.